Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
69.13 USD | -0.80% | -0.27% | +25.37% |
Mar. 27 | ANI Pharmaceuticals, Inc. Announces the Launch of Levofloxacin Oral Solution, USP | CI |
Mar. 15 | Capital One Initiates ANI Pharmaceuticals at Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.37% | 1.36B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock ANI Pharmaceuticals, Inc. - Nasdaq
- News ANI Pharmaceuticals, Inc.
- ANI Pharmaceuticals : Q4 Adjusted Earnings Drop, Revenue Rises; Acquires Novitium Pharma for $163.5 Million